Surgalign Holdings Inc
F:RT2
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sunac China Holdings Ltd
HKEX:1918
|
CN |
|
UMT United Mobility Technology AG
XETRA:UMDK
|
DE |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its Industry Average (16.1), the stock would be worth €-86.48 (2 954% downside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.6 | €3.03 |
0%
|
| Industry Average | 16.1 | €-86.48 |
-2 954%
|
| Country Average | 13.3 | €-71.79 |
-2 469%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
S
|
Surgalign Holdings Inc
F:RT2
|
20.1m EUR | -0.6 | -0.5 | |
| JP |
|
Hoya Corp
TSE:7741
|
10T JPY | 39.8 | 40 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
63.4B USD | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
31.1B CHF | 16.8 | 39 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
101.1B DKK | 14.4 | 24.8 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.7B USD | 23.1 | 33.3 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.6B GBP | 13 | 35 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.9B USD | 20.9 | -16.4 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
919.3B JPY | 22.7 | 52 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.4T KRW | -90.4 | -38 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.4B USD | 13.9 | 23.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.8 |
| Median | 13.3 |
| 70th Percentile | 20.1 |
| Max | 3 188 432.5 |
Other Multiples
Surgalign Holdings Inc
Glance View
Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. The company is headquartered in Deerfield, Illinois and currently employs 231 full-time employees. The company went IPO on 2000-08-10. The firm is focused on developing an augmented reality (AR) and artificial intelligence (AI) digital surgery platform called HOLO AI, which is an artificial intelligence technology being applied to surgery. The technology is designed to automatically segment and identify detailed patient spine anatomy, autonomously create a surgical plan for surgeon review, and then provide visual guidance with augmented reality to the surgeon in the surgical field. The company has a portfolio of spinal hardware implants, including solutions for fusion procedures in the lumbar, thoracic, and cervical spine, motion preservation solutions for the lumbar spine, and a minimally invasive surgical implant system for fusion of the sacroiliac joint. The company also has a biomaterials portfolio of advanced and traditional orthobiologics. The firm offers its products to hospitals, ambulatory surgery centers and healthcare providers in the United States.
